News

Ionis Pharmaceuticals announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen) for which Ionis earned $5 million.…
Read More...

Cerecor Inc. and TRx Pharmaceuticals, LLC (TRx) announced that the companies have entered into a purchase agreement in which Cerecor will acquire TRx, including subsidiary Zylera…
Read More...

Samsung Bioepis Co., Ltd. announced the European Commission’s (EC) marketing authorization of ONTRUZANT, a biosimilar referencing Herceptin (trastuzumab), for the treatment of early…
Read More...

AVEO Oncology announced the appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance, effective November 20, 2017. In this role, Dr. Mehta will…
Read More...

Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the Company’s product candidate, DaxibotulinumtoxinA for Injection…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved a new indication for Faslodex(fulvestrant), expanding the indication to include use with abemaciclib, a…
Read More...

Cue Biopharma announced a strategic research collaboration and license agreement with Merck, known as MSD outside of the United States and Canada. Under the terms of the deal, the CUE…
Read More...

TESARO announced that the European Commission (EC) has granted marketing authorization for ZEJULA®(niraparib) as a monotherapy for the maintenance treatment of adult patients with…
Read More...

kaléo announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for AUVI-Q®(epinephrine injection, USP) 0.1 mg, the first and…
Read More...

WuXi AppTec announced that its Advanced Therapy Unit based in Philadelphia has been selected as a manufacturing partner for advanced therapies through the California Institute for…
Read More...

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG. Under the…
Read More...

Voluntis announced that Insulia, its digital companion for people with Type 2 diabetes, has received FDA clearance and the CE mark to integrate Basaglar and Tresiba. This now makes…
Read More...

Roche announced the launch of the DISCOVERY Teal HRP kit, the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell…
Read More...

Alcami Corporation announces the official opening of a new West Coast sales office in the heart of La Jolla at 4660 La Jolla Village Drive, Suite 100, San Diego, California. The…
Read More...

Purdue Pharma L.P. today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet…
Read More...

Syngene International announced that it has expanded its ongoing collaboration with Bristol-Myers Squibb. The next phase of the partnership will see the addition of a new facility to…
Read More...

Ascentage Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for APG-1387, a novel small molecule IAP…
Read More...

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech, a member of the Roche Group, for the development of new therapeutics using Arvinas' novel PROTAC…
Read More...

Evonik is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. It now offers RESOMER Zero and RESOMER Sterile versions of both…
Read More...

Theravance Biopharma and Mylan announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for revefenacin (TD-4208), an investigational…
Read More...